Acute disseminated encephalomyelitis pathophysiology

Jump to navigation Jump to search

Acute disseminated encephalomyelitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute disseminated encephalomyelitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute disseminated encephalomyelitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute disseminated encephalomyelitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute disseminated encephalomyelitis pathophysiology

CDC on Acute disseminated encephalomyelitis pathophysiology

Acute disseminated encephalomyelitis pathophysiology in the news

Blogs on Acute disseminated encephalomyelitis pathophysiology

Directions to Hospitals Treating Acute disseminated encephalomyelitis

Risk calculators and risk factors for Acute disseminated encephalomyelitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

The exact mechanism of acute disseminated encephalomyelitis is not determined. However, it is usually preceded by an environmental trigger, e.g. an infection or vaccination and affects individuals with a genetic predisposition.

Pathophysiology[1]

Current pathogenic concepts developed from animal models[5]

Inflammatory cascade concept[6]

Molecular mimicry concept[6]

References

  1. Torisu H, Okada K (2019). "Vaccination-associated acute disseminated encephalomyelitis". Vaccine. 37 (8): 1126–1129. doi:10.1016/j.vaccine.2019.01.021. PMID 30683508.
  2. VAN BOGAERT L (1950). "Post-infectious encephalomyelitis and multiple sclerosis; the significance of perivenous encephalomyelitis". J Neuropathol Exp Neurol. 9 (3): 219–49. doi:10.1097/00005072-195007000-00001. PMID 15437201.
  3. Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P (1987). "Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination". N Engl J Med. 316 (7): 369–74. doi:10.1056/NEJM198702123160703. PMID 2433582.
  4. Plesner AM, Arlien-Soborg P, Herning M (1998). "Neurological complications to vaccination against Japanese encephalitis". Eur J Neurol. 5 (5): 479–485. doi:10.1046/j.1468-1331.1998.550479.x. PMID 10210877.
  5. Lipton HL (1975). "Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination". Infect Immun. 11 (5): 1147–55. doi:10.1128/iai.11.5.1147-1155.1975. PMC 415190. PMID 164412.
  6. 6.0 6.1 Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP; et al. (2005). "Acute disseminated encephalomyelitis: an update". Arch Neurol. 62 (11): 1673–80. doi:10.1001/archneur.62.11.1673. PMID 16286539.

Template:WS Template:WH